ABIONYX Pharma SA (EPA:ABNX)
France · Delayed Price · Currency is EUR 1.808
-0.038 (-2.06%)
Aug 15, 2025, 5:35 PM CET
ABIONYX Pharma Market Cap
ABIONYX Pharma has a market cap or net worth of €62.70 million as of August 15, 2025. Its market cap has increased by 44.64% in one year.
Market Cap
62.70M
Enterprise Value
62.22M
Revenue
4.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.81
Market Cap Chart
Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 62.70M, a decrease of -70.72%. That is a compound annual growth rate of -11.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 62.70M | 51.93% |
| Dec 31, 2024 | 41.27M | -0.54% |
| Dec 29, 2023 | 41.49M | -14.37% |
| Dec 30, 2022 | 48.45M | -28.38% |
| Dec 31, 2021 | 67.65M | 178.53% |
| Dec 31, 2020 | 24.29M | 229.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 117.04B |
| Sanofi | 99.57B |
| Sartorius Stedim Biotech | 17.23B |
| bioMérieux | 14.75B |
| Eurofins Scientific SE | 11.87B |
| Ipsen | 8.82B |
| ABIVAX Société Anonyme | 4.51B |
| Virbac | 2.75B |